These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9729018)

  • 1. Sorting the hype from the facts in melanoma.
    Autier P; Boyle P; Doré JF
    Lancet; 1998 Aug; 352(9129):738-9. PubMed ID: 9729018
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant therapy of melanoma.
    Retsas S
    Lancet; 1998 Aug; 352(9129):737-8. PubMed ID: 9729017
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant interferon in the treatment of melanoma.
    Middleton MR
    Br J Cancer; 1999 Aug; 80(11):1679-80. PubMed ID: 10468281
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant interferon alfa-2b for high-risk melanoma.
    Retsas S
    J Clin Oncol; 1996 Jun; 14(6):1968-9. PubMed ID: 8656272
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant IFN alpha2 therapy of melanoma.
    Kirkwood JM
    Lancet; 1998 Jun; 351(9120):1901-3. PubMed ID: 9654253
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical prognostic factors in adjuvant melanoma trial.
    Nathanson L
    J Clin Oncol; 1996 Jun; 14(6):1967-8. PubMed ID: 8656271
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon adjuvant therapy of melanoma.
    Kirkwood JM; Wazer D; Rosenstein M
    Cancer; 1997 May; 79(9):1843-6. PubMed ID: 9129006
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
    Johnson DM; Hayat SQ; Burton GV
    J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
    [No Abstract]   [Full Text] [Related]  

  • 9. [High-dose interferon-alpha and adjuvant treatment of melanoma with poor prognosis: requiem for a drug marketing license?].
    Saiag P
    Ann Dermatol Venereol; 1999 Mar; 126(3):211-3. PubMed ID: 10394432
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma.
    Lohmann CP; Kroher G; Bogenrieder T; Spiegel D; Preuner J
    Lancet; 1999 Apr; 353(9161):1326. PubMed ID: 10218534
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of animal-type melanoma (or pigmented epithelioid melanocytoma?): an open prognosis.
    Vezzoni GM; Martini L; Ricci C
    Dermatol Surg; 2008 Jan; 34(1):105-9; discussion 110. PubMed ID: 18053035
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma--part 2: management.
    Thirlwell C; Nathan P
    BMJ; 2008 Dec; 337():a2488. PubMed ID: 19047194
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of melanoma with allogeneic melanoma lysates alone or with interferon-alfa.
    Mitchell MS; Darrah D; Stevenson L
    Cancer Invest; 2002; 20(5-6):759-68. PubMed ID: 12197233
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent laryngeal metastasis of a malignant melanoma: surgical therapy with the first application of mitomycin C.
    Echternach M; Arndt S; Mattern D; Maier W; Richter B
    J Otolaryngol Head Neck Surg; 2009 Feb; 38(1):E19-22. PubMed ID: 19344599
    [No Abstract]   [Full Text] [Related]  

  • 15. [Melanoma during pregnancy].
    Pagès C; Misset JL; de Kerviler E; Bavoux F; Fernandez H; Viguier M
    Ann Dermatol Venereol; 2012 Apr; 139(4):298-304; quiz 296-7, 306-7. PubMed ID: 22482486
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].
    Bernengo MG; Doveil GC; Appino A; Sertoli MR; Ardizzoni A; Vidili MG
    G Ital Dermatol Venereol; 1988 Apr; 123(4):185-8. PubMed ID: 3182009
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hypotension following inadvertent intravenous administration of interferon alfa-2a.
    Hanson DS; Leggette CT
    Ann Pharmacother; 1997 Mar; 31(3):371-2. PubMed ID: 9066950
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant therapy of melanoma: at what cost?
    Spitler LE
    J Clin Oncol; 2001 Feb; 19(4):1226-8. PubMed ID: 11181688
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival benefit in melanoma.
    Williams MV; De Takats P; Parmar M
    J Clin Oncol; 1997 May; 15(5):2172. PubMed ID: 9164233
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice.
    Ravaud A; Bedane C; Geoffrois L; Lesimple T; Delaunay M
    Br J Cancer; 1999 Aug; 80(11):1767-9. PubMed ID: 10468294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.